Skip to main content

Research Repository

Advanced Search

Treatment of pulmonary exacerbations in cystic fibrosis

Ng, Christabella; Nadig, Tejaswi; Smyth, Alan R.; Flume, Patrick

Treatment of pulmonary exacerbations in cystic fibrosis Thumbnail


Authors

Christabella Ng

Tejaswi Nadig

Alan R. Smyth

Patrick Flume



Abstract

Purpose of review

This review will discuss the challenges of defining a pulmonary exacerbations in cystic fibrosis and the key pathogens, which contribute. It will discuss the treatment options currently available and the importance of preventing pulmonary exacerbations.

Recent findings

The basis for treatment of pulmonary exacerbations remains unchanged over the past 15 years and whilst there have been trials exploring alternative antibiotics, there has been little change. However, there are ongoing studies that are expected to establish a platform for identifying best practices. Chronic cystic fibrosis therapies have been shown to reduce pulmonary exacerbations. In the era of new CFTR (cystic fibrosis transmembrane conductance regulator) modulator therapies, the number of pulmonary exacerbations are expected to be even fewer. However, it is unclear whether the other chronic therapies can be discontinued without losing their benefits in reducing exacerbations.

Summary

Although there is no universal definition of a pulmonary exacerbation in cystic fibrosis, proposed definitions have many similarities. We have outlined the current recommendations for treatment of pulmonary exacerbations, including the duration and location of treatments. We have also summarized the key therapies used for prevention of pulmonary exacerbations in cystic fibrosis.

Citation

Ng, C., Nadig, T., Smyth, A. R., & Flume, P. (2020). Treatment of pulmonary exacerbations in cystic fibrosis. Current Opinion in Pulmonary Medicine, 26(6), 679-684. https://doi.org/10.1097/mcp.0000000000000730

Journal Article Type Article
Acceptance Date Aug 25, 2020
Online Publication Date Sep 2, 2020
Publication Date Nov 1, 2020
Deposit Date Oct 7, 2020
Publicly Available Date Sep 3, 2021
Journal Current Opinion in Pulmonary Medicine
Print ISSN 1070-5287
Publisher Lippincott, Williams & Wilkins
Peer Reviewed Peer Reviewed
Volume 26
Issue 6
Pages 679-684
DOI https://doi.org/10.1097/mcp.0000000000000730
Keywords cystic fibrosis, pulmonary exacerbations, treatment
Public URL https://nottingham-repository.worktribe.com/output/4945073
Publisher URL https://journals.lww.com/co-pulmonarymedicine/Abstract/2020/11000/Treatment_of_pulmonary_exacerbations_in_cystic.12.aspx

Files





Downloadable Citations